Clement, Kendell
Rees, Holly
Canver, Matthew C.
Gehrke, Jason M.
Farouni, Rick
Hsu, Jonathan Y.
Cole, Mitchel A.
Liu, David R.
Joung, J. Keith http://orcid.org/0000-0001-5630-5645
Bauer, Daniel E.
Pinello, Luca http://orcid.org/0000-0003-1109-3823
Article History
First Online: 26 February 2019
Competing interests
: At the time of manuscript preparation, J.M.G. was a consultant for Beam Therapeutics, and now is employed by Beam Therapeutics. J.K.J. has financial interests in Beam Therapeutics, Editas Medicine, Endcadia, EpiLogic Therapeutics, Pairwise Plants, Poseida Therapeutics and Transposagen Biopharmaceuticals. J.K.J.’s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. J.K.J. is a member of the Board of Directors of the American Society of Gene and Cell Therapy. J.M.G. and J.K.J. are co-inventors on patents and patent applications that describe gene editing technologies. D.R.L. is a consultant and cofounder of Editas Medicine, Pairwise Plants and Beam Therapeutics, companies that use genome editing.